3 recruiting, 1 active not recruiting, 1 unknown. 3 Phase 2, 1 Not applicable, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Recruiting 1, Unknown 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Recurrent Nasopharyngeal Squamous Cell Carcinoma: new trials by email Literature Review of Recurrent Nasopharyngeal Squamous Cell Carcinoma trials Research Report on Recurrent Nasopharyngeal Squamous Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation Audiometric Test, Interview - Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Cutaneous Squamous Cell Carcinoma of the Head and Neck | Not applicable | Recruiting | Emory University | 118 | 2025-08-25 | 2026-07-16 |
| TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer Autologous Tumor Membrane Vesicles Vaccine, Biospecimen Collection, Computed Tomography - Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma | Phase 1 | Recruiting | Emory University | 40 | 2025-05-08 | 2026-03-04 |
| Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial Biospecimen Collection, Computed Tomography, Lovastatin - Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown Primary | Phase 2 | Recruiting | Emory University | 28 | 2024-12-09 | 2026-02-11 |
| Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers Atezolizumab, Bevacizumab, Biospecimen Collection - Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma | Phase 2 / Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 430 | 2023-03-13 | 2026-10-01 |
| Concurrent Chemoradiotherapy With Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma: a Prospective, Single-arm, Phase II Trial Toripalimab - Nasopharyngeal Carcinoma, Toripalimab | Phase 2 | Unknown | Cancer Hospital of Guangxi Medical University | 40 | 2020-06-28 | 2021-08-20 |
Nasopharyngeal Carcinoma (5) · Carcinoma (4) · Hypopharyngeal Neoplasms (4) · Laryngeal Neoplasms (4) · Mouth Neoplasms (4) · Oropharyngeal Neoplasms (4) · Squamous Cell Carcinoma of Head and Neck (4) · Lymphoid Interstitial Pneumonia (1) · Recurrence (1)
Head and Neck Neoplasms (5) · Nasopharyngeal Diseases (5) · Nasopharyngeal Neoplasms (5) · Neoplasms (5) · Neoplasms by Histologic Type (5) · Neoplasms by Site (5) · Neoplasms, Glandular and Epithelial (5) · Otorhinolaryngologic Diseases (5) · Otorhinolaryngologic Neoplasms (5) · Pharyngeal Diseases (5) · Pharyngeal Neoplasms (5) · Stomatognathic Diseases (5) · Carcinoma, Squamous Cell (4) · Laryngeal Diseases (4) · Mouth Diseases (4)
Magnetic Resonance Spectroscopy (3) · Specimen Handling (3) · pembrolizumab (2) · (225)Ac-DOTA-c(RGDyK) (1) · 1,2-diaminocyclohexaneplatinum II citrate (1) · Bevacizumab (1) · Carboplatin (1) · Cetuximab (1) · Cisplatin (1) · Disulfides (1) · Docetaxel (1) · Hearing (1) · Immunoglobulin G (1) · Interviews as Topic (1) · Lovastatin (1)
Emory University (3) · Cancer Hospital of Guangxi Medical University (1) · National Cancer Institute (NCI) (1)
United States (4) · China (1)
Aarti Bhatia (1) · Dong M. Shin, MD, FACP, FAAAS (1) · Nicole C Schmitt, D, FACS (1) · Nicole C Schmitt, MD, FACS (1)
PMID 11224527, PMID 16382236, PMID 18173375, PMID 30207593
P30CA138292 (3), K24DC022077 (1), R01CA262123 (1), U10CA180820 (1)